Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007;2007(6):90520.
doi: 10.1155/2007/90520.

DNA Vaccines against Protozoan Parasites: Advances and Challenges

Eric Dumonteil  1
Affiliations

DNA Vaccines against Protozoan Parasites: Advances and Challenges

Eric Dumonteil. J Biomed Biotechnol. 2007.

Abstract

Over the past 15 years, DNA vaccines have gone from a scientific curiosity to one of the most dynamic research field and may offer new alternatives for the control of parasitic diseases such as leishmaniasis and Chagas disease. We review here some of the advances and challenges for the development of DNA vaccines against these diseases. Many studies have validated the concept of using DNA vaccines for both protection and therapy against these protozoan parasites in a variety of mouse models. The challenge now is to translate what has been achieved in these models into veterinary or human vaccines of comparable efficacy. Also, genome-mining and new antigen discovery strategies may provide new tools for a more rational search of novel vaccine candidates.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Liu MA, Wahren B, Hedestam GBK. DNA vaccines: recent developments and future possibilities. Human Gene Therapy. 2006;17(11):1051–1061. - PubMed
    1. Murray HW, Berman JD, Davies CR, Saravia NG. Advances in leishmaniasis. The Lancet. 2005;366(9496):1561–1577. - PubMed
    1. Alexander J, Bryson K. T helper (h)1/Th2 and Leishmania: paradox rather than paradigm. Immunology Letters. 2005;99(1):17–23. - PubMed
    1. McMahon-Pratt D, Alexander J. Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease? Immunological Reviews. 2004;201(1):206–224. - PubMed
    1. Castro JA, de Mecca MM, Bartel LC. Toxic side effects of drugs used to treat Chagas' disease (American trypanosomiasis) Human and Experimental Toxicology. 2006;25(8):471–479. - PubMed

LinkOut - more resources